Comparison of the Beverage Hydration Index of Different Solutions
1 other identifier
interventional
29
1 country
1
Brief Summary
The present study will assess the effects of two different hydration solutions compared to water on hydration measures. It will follow the same approach as used by Maughan and colleagues (2016) to measure the fluid balance (the difference between the amount of water consumed and passed as urine) and beverage hydration index (the relative amount of urine passed after consumption of a drink compared to water) including time in positive fluid balance. Additionally, hydration status will be assessed with mood and digestive health questionnaires and blood pressure urine electrolyte concentrations, specific gravity, and osmolality determinations. The two oral rehydration solutions (Berry Propel Fitness Water and Essentia Hydroboost Raspberry Pomegranate) will be compared to the control (Smart Water). The purpose is to assess whether the changes in beverage composition improve the BHI above water alone for both treatments, with an hypothesized greater improvement in BHI observed with the Essentia Hydroboost Raspberry Pomegranate, due to the addition of carbohydrate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2024
CompletedFirst Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2025
CompletedApril 8, 2025
April 1, 2025
4 months
December 10, 2024
April 5, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Beverage Hydration Index
Beverage Hydration Index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment
0 minutes after beverage consumption
Beverage Hydration Index
Beverage Hydration Index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment
60 minutes after beverage consumption
Beverage Hydration Index
Beverage Hydration Index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment
120 minutes after beverage consumption
Beverage Hydration Index
Beverage Hydration Index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment
180 minutes after beverage consumption
Beverage Hydration Index
Beverage Hydration Index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment
240 minutes after beverage consumption
Secondary Outcomes (56)
Net Fluid Balance
0 minutes after beverage consumption
Net Fluid Balance
60 minutes after beverage consumption
Net Fluid Balance
120 minutes after beverage consumption
Net Fluid Balance
180 minutes after beverage consumption
Net Fluid Balance
240 minutes after beverage consumption
- +51 more secondary outcomes
Study Arms (6)
Propel, Essentia, Smart
EXPERIMENTALSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Propel, Smart, Essentia
EXPERIMENTALSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Essentia, Smart, Propel
EXPERIMENTALSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Essentia, Propel, Smart
ACTIVE COMPARATORSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Smart, Essentia, Propel
EXPERIMENTALSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Smart, Propel, Essentia
EXPERIMENTALSubjects will follow control diet for 24 hours prior to visit. At the study visit, baseline measures will be collected prior to treatment. Subjects will consume the assigned treatment (one treatment per visit in order state in arm title) and additional experimental measurements will be collected.
Interventions
Subject will consume 1 Liter of commercially available Berry Propel Fitness Water at a rate of 250 milliliters per 7.5 minutes
Subject will consume 1 Liter of commercially available Essentia Hydroboost Raspberry Pomegranate at a rate of 250 milliliters per 7.5 minutes
Subject will consume 1 Liter of commercially available Smart Water at a rate of 250 milliliters per 7.5 minutes.
Eligibility Criteria
You may qualify if:
- body mass index (BMI) \<35 kg/m2 (not morbidly obese)
- Cannot have a sensitivity or be allergic to any components of the study product they will be excluded.
- non-tobacco user
- cannot be following a specialized dietary pattern that may alter findings (e.g., low carbohydrate/ketogenic diet, carnivore diet, intermittent fasting etc.)
- willing to replicate the same dietary intake/activity (exercise) level for each day before a lab visit excluding screening
- Will consume a minimum of 2 liters (women) or 2.5 liters (men) of water per day, on each day prior to experimental lab visits (excluding screening)
- Will arrive to lab for visits euhydrated (USG 1.005-1.020)
- Will not consume alcohol-containing beverages within 24 hours of testing
- Will not consume caffeine-containing beverages within 12 hours of testing
- can fast (consume water/treatments only) for 15 hours (10 hours prior to lab visits not including screening)
- avoid strenuous activity for 24 hours prior to study visits excluding screening
- Will not have a history or presence of a clinically relevant (that required or requires treatment) cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder (reviewed by Nurse practitioner)
- Will not have other conditions that is likely to alter fluid balance or be negatively affected by changing electrolyte levels/hydration status (as determined by Nurse practitioner)
- Is not consuming any medication which may alter fluid retention/electrolyte levels such as sodium-glucose co-transporter 2 (SGLT2) inhibitor (for type 2 diabetes), laxatives, diuretics, Apremilast, chemotherapy, or lithium. (Medications will be reviewed by Nurse practitioner)
- Will not consume nutritional supplements, performance enhancing drugs, and/or non-steroidal anti-inflammatory drugs within 7 days of study visits excluding screening.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, 38152, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Richard J Bloomer, PhD
University of Memphis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- treatments labeled A-C. Subjects will be provided the beverage in plastic cups without product labels
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of the College of Health Sciences
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
November 21, 2024
Primary Completion
March 6, 2025
Study Completion
March 21, 2025
Last Updated
April 8, 2025
Record last verified: 2025-04